AFVT-2101

N/A

Report date: 2025/01/02 16:12:14

Base Information

Drug NameAFVT-2101
Drug Alias NameAFM-32AFVT-2101
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsFolate receptor alpha modulatorsLow affinity immunoglobulin gamma Fc region receptor III-A modulators +[4] 
TargetsFolate receptor alphaLow affinity immunoglobulin gamma Fc region receptor III-A
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAffimed Nv
China Registration ClassN/A

Develop Information

Active CompaniesRoivant Sciences IncAffimed Nv
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A